- Home
- BTBT vs TSHA Comparison
BTBT vs TSHA Comparison
Compare BTBT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBT
- TSHA
- Stock Information
- Founded
- BTBT 2015
- TSHA 2019
- Country
- BTBT United States
- TSHA United States
- Employees
- BTBT N/A
- TSHA N/A
- Industry
- BTBT Finance: Consumer Services
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- BTBT Finance
- TSHA Health Care
- Exchange
- BTBT Nasdaq
- TSHA Nasdaq
- Market Cap
- BTBT 437.8M
- TSHA 356.7M
- IPO Year
- BTBT 2018
- TSHA 2020
- Fundamental
- Price
- BTBT $2.00
- TSHA $1.38
- Analyst Decision
- BTBT Strong Buy
- TSHA Strong Buy
- Analyst Count
- BTBT 3
- TSHA 8
- Target Price
- BTBT $6.33
- TSHA $6.63
- AVG Volume (30 Days)
- BTBT 15.0M
- TSHA 1.7M
- Earning Date
- BTBT 03-14-2025
- TSHA 05-13-2025
- Dividend Yield
- BTBT N/A
- TSHA N/A
- EPS Growth
- BTBT N/A
- TSHA N/A
- EPS
- BTBT 0.19
- TSHA N/A
- Revenue
- BTBT $107,500,460.00
- TSHA $8,333,000.00
- Revenue This Year
- BTBT $55.86
- TSHA N/A
- Revenue Next Year
- BTBT $65.39
- TSHA N/A
- P/E Ratio
- BTBT $11.05
- TSHA N/A
- Revenue Growth
- BTBT 139.34
- TSHA N/A
- 52 Week Low
- BTBT $1.76
- TSHA $1.19
- 52 Week High
- BTBT $5.74
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- BTBT 35.52
- TSHA 34.93
- Support Level
- BTBT $2.28
- TSHA $1.59
- Resistance Level
- BTBT $2.54
- TSHA $1.87
- Average True Range (ATR)
- BTBT 0.16
- TSHA 0.15
- MACD
- BTBT -0.00
- TSHA -0.01
- Stochastic Oscillator
- BTBT 9.48
- TSHA 24.36
Stock Price Comparison Chart: BTBT vs TSHA
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.